Chaitanya Divgi

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial
    Chaitanya R Divgi
    Columbia University, New York, NY 10032, USA
    J Clin Oncol 31:187-94. 2013
  2. doi request reprint Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer
    Chaitanya Divgi
    Columbia University, New York, NY, USA
    Semin Nucl Med 41:369-73. 2011
  3. ncbi request reprint Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer
    Michael J Morris
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 444, New York, NY 10021, USA
    Curr Urol Rep 6:163-70. 2005
  4. ncbi request reprint Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Health Phys 92:33-9. 2007
  5. ncbi request reprint Current status of therapy of solid tumors
    Yuliya S Jhanwar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 46:141S-50S. 2005
  6. doi request reprint Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results
    Patrick G Morris
    Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Clin Breast Cancer 10:33-9. 2010
  7. ncbi request reprint Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels
    Lee M Krug
    Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Medical College at Cornell University, New York, NY 10021, USA
    J Thorac Oncol 2:947-52. 2007
  8. doi request reprint Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Nucl Med 38:S30-9. 2008
  9. ncbi request reprint Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer
    Michael J Morris
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 444, New York, NY 10021, USA
    Curr Oncol Rep 6:222-9. 2004
  10. ncbi request reprint Imaging: staging and evaluation of lymphoma using nuclear medicine
    Chaitanya Divgi
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 32:S11-8. 2005

Collaborators

Detail Information

Publications12

  1. doi request reprint Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial
    Chaitanya R Divgi
    Columbia University, New York, NY 10032, USA
    J Clin Oncol 31:187-94. 2013
    ..A clinical study to characterize renal masses with positron emission tomography/computed tomography (PET/CT) was undertaken...
  2. doi request reprint Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer
    Chaitanya Divgi
    Columbia University, New York, NY, USA
    Semin Nucl Med 41:369-73. 2011
    ..This review will attempt to compliment the excellent existing literature by providing an overall systemic therapeutic approach to this promising endeavor...
  3. ncbi request reprint Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer
    Michael J Morris
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 444, New York, NY 10021, USA
    Curr Urol Rep 6:163-70. 2005
    ..In this article, we review the rationale behind this approach, the targets being explored, the radiation sources available, and the antibodies currently under clinical development...
  4. ncbi request reprint Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma
    Lawrence T Dauer
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Health Phys 92:33-9. 2007
    ....
  5. ncbi request reprint Current status of therapy of solid tumors
    Yuliya S Jhanwar
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Nucl Med 46:141S-50S. 2005
    ..This review will describe seminal studies that have paved the way to an understanding of radioimmunotherapy in solid tumors. Finally, the authors' views of the future of this promising cancer therapy will be presented...
  6. doi request reprint Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results
    Patrick G Morris
    Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Clin Breast Cancer 10:33-9. 2010
    ..A prospective clinical study was designed to explore this hypothesis. Patients and..
  7. ncbi request reprint Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels
    Lee M Krug
    Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Medical College at Cornell University, New York, NY 10021, USA
    J Thorac Oncol 2:947-52. 2007
    ..A phase I trial of humanized 3S193 (hu3S193) with dosing up to 40 mg/m2 demonstrated tumor targeting without serious toxicities or the development of human anti-human antibodies...
  8. doi request reprint Patient-specific radiation dosimetry for radionuclide therapy of liver tumors with intrahepatic artery rhenium-188 lipiodol
    Pat B Zanzonico
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Nucl Med 38:S30-9. 2008
    ..Although not required for treatment planning, tumor absorbed dose may also be estimated. This algorithm has been automated using an Excel (Microsoft, Redmond, WA) spreadsheet...
  9. ncbi request reprint Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer
    Michael J Morris
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 444, New York, NY 10021, USA
    Curr Oncol Rep 6:222-9. 2004
    ..In this article, we review the rationale behind this approach, the targets being explored, the radiation sources available, and the antibodies currently under clinical development...
  10. ncbi request reprint Imaging: staging and evaluation of lymphoma using nuclear medicine
    Chaitanya Divgi
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 32:S11-8. 2005
    ..This article examines the role of the different imaging techniques available and the use of these techniques in the staging and evaluation of patients with Hodgkin's and non-Hodgkin's lymphoma...
  11. ncbi request reprint A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    Richard J Robbins
    Endocrinology Service, Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Nucl Med 43:1482-8. 2002
    ..During this same time period, other patients at our center were prepared for RRA by hormone withdrawal...
  12. ncbi request reprint Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography
    Ann Marie Chacko
    Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA
    Med Chem 7:395-412. 2011
    ..The review will conclude by highlighting promising future directions in using (124)I as a positron emitter in PET radiochemistry and molecular imaging...